Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Baxter
Argus Health
Fish and Richardson
Citi
Dow
Harvard Business School
McKesson
Cerilliant

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020626

« Back to Dashboard

NDA 020626 describes IMITREX, which is a drug marketed by Glaxosmithkline and is included in three NDAs. It is available from five suppliers. Additional details are available on the IMITREX profile page.

The generic ingredient in IMITREX is sumatriptan. There are twenty-four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sumatriptan profile page.
Summary for 020626
Tradename:IMITREX
Applicant:Glaxosmithkline
Ingredient:sumatriptan
Patents:0
Therapeutic Class:Antimigraine Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 020626
Medical Subject Heading (MeSH) Categories for 020626
Suppliers and Packaging for NDA: 020626
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IMITREX sumatriptan SPRAY;NASAL 020626 NDA GlaxoSmithKline LLC 0173-0523 N 0173-0523-00
IMITREX sumatriptan SPRAY;NASAL 020626 NDA GlaxoSmithKline LLC 0173-0524 N 0173-0524-00

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SPRAY;NASALStrength5MG/SPRAY
Approval Date:Aug 26, 1997TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SPRAY;NASALStrength10MG/SPRAY
Approval Date:Aug 26, 1997TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:SPRAY;NASALStrength20MG/SPRAY
Approval Date:Aug 26, 1997TE:ABRLD:Yes

Expired US Patents for NDA 020626

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-002 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-002 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-001 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Glaxosmithkline IMITREX sumatriptan SPRAY;NASAL 020626-003 Aug 26, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Covington
Queensland Health
Daiichi Sankyo
Cantor Fitzgerald
Citi
Moodys
Dow
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.